Changes in genomic methylation and its significance in carcinogenesis is in the spotlight once again, though the focus is not on the usual suspects, DNA hypermethylation and tumour suppressor gene (TSG) silencing. Several recent reports provide compelling evidence of the relevance of genomic hypomethylation in cancer. These findings provide the best evidence so far that links the loss of DNA methylation and chromosomal instability with cancer development. This review article discusses these recent findings and reflects on the antithetical association between DNA methylation and carcinogenesis and the re-examination of studies performed almost two decades ago. 
The two sides of genomic methylation
The genome is exquisitely packaged as a physical entity comprising deoxyribonucleic acid that contains the template for genetic information. In eukaryotes, histone and nonhistone proteins package nuclear DNA into nucleosomes and higher order chromatin structures that make up the chromosome. The modification of genomic DNA and the protein components of chromatin regulate critical molecular processes such as transcriptional control, DNA replication and repair, chromosome segregation and genomic stability. The covalent modification of DNA by methylation is one of the best characterized epigenetic changes. [1] [2] [3] [4] [5] The events that regulate chromatin structure and transcriptional competence mediated by changes in epigenetic regulation are also beginning to be understood. 5 Yet, the link between genomic methylation and the progression of cancer has been a source of intense controversy for many years. 6 This has led researchers to investigate the biological role of DNA methylation in cancer. Are elevated or reduced genomic methylation patterns associated with cancer progression? The answer appears to be both, at least in different model systems regardless of whether they be losses or gains in the methylation moiety. Hypermethylation of CpG sequences is generally associated with gene silencing and the identification of putative TSGs and the characterization of bona fide genes continues to grow at a rapid pace. 7, 8 There is ample evidence that supports a critical role for promoter methylation in oncogenesis in primary as well as cultured tumour cells. 9, 10 Indeed, this change in genomic methylation has become pertinent mark in the field of cancer epigenetics. Recent studies disrupting the DNA methyltransferase genes, DNMT1 and DNMT3b, reduce the overall genomic methylation content and alleviate repression of p16INK4a and TIMP3. 11 Somatic knockout of the DNMT3b gene reduces the global methylation levels by 3% and almost 20% when the DNMT1 gene is disrupted. Unexpectedly, double knockouts (DKOs) show complete genomic methylation loss which correlates with the reversal of gene silencing.
11 DNMT1 null cells treated with the demethylating agent, 5-aza 2 0 -deoxycytidine (5adC), show p16 demethylation and gene reactivation. These results present the most compelling demonstration to date of the involvement of DNA methylation and the DNMT enzymes in an experimental model of colorectal cancer. In view of these results, the cooperation between DNMT1 and DNMT3b methylases may provide an explanation as to why DNMT1 knockouts in other studies retain their genomic methylation patterns and TSGs remain transcriptionally repressed. 12 However, what of the confounding data that genomic hypomethylation is also directly associated with tumour progression? Investigators have known for some time that genomic methylation contents are significantly lower in cancer. 13 Furthermore, the demethylating agent 5adC has been used to demonstrate genomic hypomethylation 14 and is indeed relevant given the increasing profile of DNA demethylating agents as prospective anticancer drugs. 15 These studies pose some interesting questions. Can reductions in DNA methylation inadvertently promote tumorigenesis and does this represent a separate role for methylation events in cancer? Almost two decades ago, Feinberg and Vogelstein 4 demonstrated that focal and global genomic hypomethylation was associated with cancer progression. Given that DNA methylation has a significant role in gene expression, it is attractive to suggest that gene deregulation underlies tumorigenesis. Indeed this is a common theme with TSG silencing, however, we require a better understanding of the functional significance of methylation changes and the molecular events that predispose normal cells to transform.
If DNA hypomethylation can predispose cells to chromosomal rearrangements, then the recent findings that DNMT3b mutations cause immunodeficiency, centromeric instability and facial abnormalities (ICF) syndrome provide some clues that demethylation destabilizes overall chromatin organization. 16 Chromosomes (Ch) 1, 9 and 16 comprise DNA-satellite repeats that are normally methylated in leucocytes; however, ICF individuals undergo abnormal genomic hypomethylation resulting in decondensed heterochromatin. 17, 18 Somewhat analogous to tumour development models, alterations in the methylation pattern may predispose cells to chromosomal instability with abnormal changes in chromatin organization. genomic hypomethylation are the changes in DNA stability and chromatin undercondensation. 20 The knockout of DNMT3b in embryonic stem cells promotes genome-wide destabilization. 21 Jaenisch and co-workers recently generated heterozygote mice using a hypomorphic allele for DNMT1 combined with a null allele to demonstrate the importance of DNA hypomethylation in cancer development. 2, 3 Given that DNA methyltransferase knockouts are either embryonic or perinatal lethal, DNMT1 hypomorphic mice were generated with widespread loss of genomic methylation in all tissues without compromising animal development. [21] [22] [23] . Mice hypomorphic for the DNMT1 allele show overall reduced genomic methylation content. Furthermore, mutated mice are runted at birth and T-cell tumours display c-myc overexpression; whereas DNMT1 control mice developed normally with no tumour formation and were diploid for c-myc. How hypomethylation induces genomic instability is not yet clear; however, comparative genome hybridization analysis revealed significant changes in chromosomal gains and losses in the hypomethylated tumours. Gains in Ch14 and -15 in the T-cell lymphomas had elevated c-myc gene expression corresponding with multiple copies of Ch15. Similar correlations were made in tumour-prone mice that are heterozygotes for the neurofibromatosis 1 (Nf1 þ /À) and p53 (p53 þ / À) TSGs. 24 The NPcis (Nf1 þ /À p53 þ /À) mice develop softtissue sarcomas with loss of heterozygosity (LOH) of both Nf1 and p53 alleles on Ch11. In a different scenario, Jaenisch and co-workers induced genomic hypomethylation in the NPcis mice by introducing the DNMT1 hypomorphic allele.
3 These mice develop sarcomas at an earlier age with reduced genomic methylation when compared to NPcis mice with normal methylation levels. Comparisons show significant increases in LOH events in hypomethylated cells. These results suggest that genomic hypomethylation and chromosomal instability play important roles in tumorigenesis.
How epigenetic changes such as methylation loss are brought about to cause genome instability is not well understood; however, it is worthwhile comparing other model systems. For example, hypomethylation of highly repetitive satellite sequences in lymphoblasts show chromosomal aberrations including breakages and rearrangements. 25 An interesting association is also proposed between microsatellite integrity, DNA repair and methylation deficiency in cancer. 26 Mutations in the mismatch repair gene 1 (MLH1) reduce chromosomal stability by several-hundred fold and is postulated to be involved in the collapse of DNA polymerases during mitosis and correlated with increased replication errors. 27 The significance of MLH deficiencies and whether they predispose normal cells to transform is indeed curious. Germline mutations of mismatch repair genes are associated with susceptibility. 28 Recent experimental evidence juxtapose the role of mismatch repair and DNMT1 deficiencies in cancer. Hypomorphic DNMT1 mice show genome-wide undermethylation and are free of tumours. However, when crossed with mismatch repair-deficient mice predisposed to intestinal tumours, genomic hypomethylation reduces cancer susceptibility while increasing lymphoid tumours in DNMT1 hypomorphic, MLH À/À mice. 29 From the limited number of experimental analyses performed thus far, we can only speculate that genomic hypomethylation events may protect against intestinal cancer by transcriptional activation of CpG island-linked genes, whereas enhanced lymphogenesis could be a consequence of proto-oncogene expression or MLHÀ/Àdependent genomic destabilization. The significance of each of these mechanisms on tissue-specific cancer is not well understood and requires further characterization.
Genome-wide demethylation also has a profound impact on DNA stability and transcription. Using endogenous transgenes as genetic markers for spontaneous mutation rates, Jaenisch and co-workers screened for resistant clones in DNMT1 wild-type and mutant ES cells. 30 At these loci, chromosomal integrity was compromised with significant increases in mutation rates and chromosomal deletions. These mutants acquired more genomic rearrangements and promoted LOH. These results offer an explanation as to how hypomethylation may predispose cancer cells to chromosomal instability. 2, 3, 30 It is likely that chromosomal rearrangements are functionally linked with changes in the binding distribution of molecular determinants, which could directly or indirectly influence chromatin structure and function. 31 The studies by Jaenisch and co-workers 2,3,30 raise important questions about aberrant gene regulation in cancer and now provide a reasonable cause to re-examine the role linking genomic hypermethylation and tumour progression. 1 DKOs of the DNMT1 and DNMT3b enzymes in colorectal cancer cells significantly reduce the genomic methylation content by at least 95% and methylation-dependent silencing of TSGs is alleviated. 11 This is in contrast to DNMT1À/À and DNMT3bÀ/À knockouts. 12 From a molecular perspective, it will be interesting to investigate whether DKO cells show large-scale or subtle chromosomal aberrations. The fact that DNMT DKO cells fail to methylate genomic sequences and results in chromatin reorganization is an attractive model, however, there could be inherent differences in the models studied. 2, 3, 11 The overall genomic complexity and methylation patterns differ between human and murine cells. For example, ICF individuals have characteristic genomic hypomethylation at satellite DNA, whereas murine embryo's with gene knockout of DNMT3b display persistent satellite DNA methylation. 32, 33 Secondly, mutations in the catalytic domain of ICF variants does not abrogate methylase activity 34 and may explain why Dnmt3bÀ/ À in mice is lethal, whereas ICF patients are viable. It is speculated that methylation is critical to maintain chromosome stability and failure to methylate sequences can compromise chromatin structure and gene regulation. 35 Perhaps, the most intriguing aspect of genome stability and cancer are that aneuploidy and hypomethylation are early events in tumorigenesis which is in striking contrast to euploidhypomethylated ES cells which are thought to be protected from chromosomal rearrangements. 30 In experimental models of chromosome missegregation and karyotypic instability, 36 mitotic checkpoint defects reveal that genome-wide chromosome losses have an underlying epigenetic component. 37 Whether epigenetic information initiates cell transformation by suppressing checkpoint protein regulators and consequently chromosomal instability is not entirely clear; there may well be an underlying epigenetic event to accumulate even more somatic mutations, rearrangements and replication mistakes. 38 Regardless of the exact molecular mechanisms, our understanding of DNMT and cancer will undoubtedly rely on the generation of new mice knockout strains with unique genetic backgrounds. It will also be useful to exploit existing animal models to study the significance of checkpoint regulation and the genetic events that lead up to chromosomal instability.
2,3
Genome stability and histone methylation Clearly, epigenetic marks such as genomic methylation are critical in establishing and maintaining chromatin stability. The N-terminal histone tails are also targeted and subject to covalent modifications such as acetylation, phosphorylation and methylation that appear to control a wide range of important cellular processes by regulating transcriptional competence and chromatin stability. For example, acetylation on the lysine tails of histones H2A, H2B, H3 and H4 neutralize the positive charge on the amino acid, and this modification is closely associated with allosteric changes in chromatin conformation. The functional consequence of nucleosomal histone acetylation is reciprocated with the remodelling and increased chromatin accessibility and transcriptional activity. In contrast, the transition from refractile to permissive chromatin is exquisitely regulated by histone deacetylases that catalyse the removal of acetyl groups from histone tails and this process is intimately associated with transcriptionally inactive heterochromatin. Examples of the functional significance of histone tail modifications are evident when investigators studying chromosome segregation revealed that pericentric heterochromatin appears to be underacetylated and requires phosphorylation of histone H3 for proper mitotic DNA condensation. 39 Curiously, similar observations have been made with methylation of histone tails which are thought to function as epigenetic 'marks' controlling chromosome organization and have been proposed to further contribute to the epigenetic code 40, 41 (and references therein). The lysine tail of H3 can be monomethylated at either K9 and trimethylated at K4, K27 and K36, whereas on H4 the lysine tail can be trimethylated on K20. Methylation of H3K4 (methH3K4) is almost exclusively located within euchromatin and is closely associated with transcriptional activity. 42 Most of the mechanistic insights into histone methylation have come from chromatin immunoprecipitation (ChIP) experiments. Mapping of the methH3K4 modification by ChIP show enrichment primarily in the coding regions of genes suggesting the methH3K4 mark could be involved in transcriptional elongation. 43 In contrast, methH3K9 is implicated with establishing transcriptionally repressed heterochromatin and this epigenetic phenomenon is conserved from mammals to the fruit fly and other genetically tractable organisms. [44] [45] [46] [47] [48] The exclusion of the methH3K9 mark on transcriptionally competent euchromatin in Saccharomyces cerevisiae is notable and suggests a connection between histone methylation and chromatin behaviour. 49 In mammals, histone methyltransferase (HMTase) Suv39h1 and Suv39h2 have been characterized and found to possess a highly conserved SET domain capable of catalysing the methylation of methH3K9. 50 A role for Suv39h in mediating genomic stability was further elucidated by genetic knockout of the Suv39h1/h2 genes in mice. 40 The DKO revealed the HMTases govern the methylation of H3K9 located primarily on pericentric heterochromatin and thus raises the possibility of the involvement of other HMTases in H3K9 methylation. This study also shows striking genomic instabilities and that DKO mice are predisposed to late-onset B-cell lymphomas. What is the particular link between heterochromatin behaviour and cancer? Firstly, the HMTase DKO phenotype is consistent with recent reports describing chromosomal instability, DNA hypomethylation and the development of lymphomas. 2, 3 Secondly, it is not coincidental that the epigenetic methH3K9 mark can direct changes in genomic methylation. 51 In Neurospora crassa and Arabidopsis thaliana, genomic methylation defects at pericentric heterochromatin are a consequence of Suv39-dependent histone methylation, 51, 52 curiously, however, there seem to be differences in the interrelatedness of epigenetic components in mammals. For example, DNA methylation at centromeric satellite repeats is independent of functional Suv39h HMTase, suggesting that epigenetic marks other then Suv39h-directed methylation are likely to be present. 53 Although we are beginning to understand DNMT's function in specifying DNA methylation patterns, we still do not know what dictates the methylase machinery to the DNA template and how this segregates genomic methylation patterns. The methylation defect is not just a consequence of changes in DNMT deregulation because the genomic methyltransferases are comparably expressed in normal and cancer cells. 54 Whether genomic methylation events draw on the HMTase methH3K9 que remains to be determined. The fact that methylation patterns can be specified by changes in chromatin structure (El-Osta 2003 BioEssays vol 25, pp 1071-1084) suggests that these individual processes may have a similar goal in stabilizing genomic sequences. Perhaps, it is not difficult to imagine an integrated model centred on the regulation of epigenetic determinants and the recent studies of Lsh (lymphoid-specific helicase) knockout mice show that chromatin disruption can incorrectly specify DNA methylation. 55 Reports examining the influence of histone methylation on CpG methylation do raise an important question, could all the information required to dictate epigenetic pathways ultimately reside on the histone tail? Although this is an attractive model, the interdependence of Suv39h on DNA methylation at centromeric and pericentric satellite repeats reveals a complicated relationship that selfreinforces heterochromatin. 53 While persistent modifications on methH3K9 can direct DNA methylation, these studies are complicated by the fact that the loss of DNA methylation can impact on histone methyl marks. For example, transcriptional silencing of TSGs can be reactivated by treatment with 5adC causing promoter-associated demethylation and hyperacetylation of histone H3. 56 Indeed, similar results have been described in different gene and model systems. 57, 58 Interestingly, hypomethylation and transcriptional reactivation are the accompanying changes to histone methyl marks, namely, reductions in dimethH3K9 and the selective enrichment of dimethH3K4. 56 These results suggest that while initiation of silencing is dependent on the methyl moiety on H3K9, maintenance of transcriptional repression and accompanying changes to histone methylation events are indeed mediated by DNA methylation. 45, 59 It is evident from these recent studies that our views of the mechanisms of direct methylation are still developing. While it is difficult to imagine how 5adC regulates histone H3 methylation patterns, perhaps there are striking parallels in the mechanism that directs genomic methylation content and chromosome stability. Furthermore, does 5adC regulate histone methylation directly or could structural changes mediated by DNA demethylation unmask histone methylation? Although a common theme is evident involving epigenetic mechanisms and the fidelity of genetic stability, our understanding of the genomic que that segregates the histone methylation mark remains unclear.
We are now beginning to appreciate that changes in the epigenetic 'repertoire' can destabilise heterochromatin organisation, increase chromosome missegregation and alter transcriptional control. Indeed, there appears to be an evolutionary conserved pathway between histone and genomic methylation and heterochromatin stability in fungi, plant and mammalian organisms. [51] [52] [53] Although the exact molecular events involved remain to be determined, it is believed that the link between genomic methylation and heterochromatin stability is correlated with Suv39 HMTase. 60 This connection is attractive given the recent study by Selker and co-workers that trimethH3K9 is a mark for DNA methylation and provides a functional link between these epigenetic pathways. 61 Although covalent histone modifications are crucial for regulating genomic methylation patterns in Neurospora, there seem to be exceptional differences in plants and mammals; for example, DNA methylation is dispensable in Neurospora. 62 These results clearly illustrate the subtle yet important differences that connect epigenetic modification and DNA methylation in N. crassa, A. thaliana and mammalian organisms. Thus it will be important not only to resolve the determinants involved in methylation but also the molecular criteria for maintaining chromatin stability.
Conclusion
The discovery of critical epigenetic processes that are directly involved in genomic integrity have emerged and provide a general concept for a role in the progression of cancers. The studies discussed in this review suggest that epigenetic pathways which reinforce genome integrity are not only relevant to our understanding of processes such as transcriptional activity, chromosome segregation and replication but are also critical in the developmental events involved in cancer. With the recent experimental evidence at hand, an excellent precedent exists for changes in the epigenetic information to help define the relevance of genomic instability and increased cancer risk.
